1. EPA, 1998. Endocrine Disruptor Screening Program: Statement of Policy. Federal Register 63 (248), 71541-71568. Federal Register Notice 63.
2. EPA, 2009a. Endocrine Disruptor Screening Program Test Guideline OPPTS 890.1550: Steroidogenesis (Human Cell Line - H295R).
3. EPA, 2009b. Endocrine Disruptor Screening Program Test Guideline OPPTS 890.1150: Androgen Receptor Binding (Rat Prostate Cytosol).
4. EPA, 2009c. Endocrine Disruptor Screening Program Test Guideline OPPTS 890.1200: Aromatase (Human Recombinant).
5. EPA, 2009d. Endocrine Disruptor Screening Program Test Guideline OPPTS 890.1250: Estrogen Receptor Binding (Rat Uterine Cytosol).